Here it is..
http://www.solagran.com/cikk_files/solagran_profile_by_member_insight.pdf
Solagran’s pricing strategy for Russia is yet to be
finalised; however, management has indicated that the
Russian government typically provides the first
US$1,000 of the cost of any hospital-based treatment
program. If Ropren is priced at a higher level, patients
would have to pay the excess over the state funding
level;
